Search Results - "O D Ostroumova"

Refine Results
  1. 1

    Effect of a fixed-dose combination of perindopril arginine/amlodipine on the level and variability of blood pressure according to its office visit-to-visit measurements and self-measurements at home: A subanalysis of the PREVOSHODSTVO (SUPERIORITY) program by Ostroumova, O D

    Published in Terapevtic̆eskii arhiv (01-01-2017)
    “…To study the effect of a fixed-dose combination of perindopril arginine/amlodipine (prestans) on the goal levels and variability of blood pressure (BP)…”
    Get full text
    Journal Article
  2. 2

    Worksite hypertension as a model of stress-induced arterial hypertension by Ostroumova, O D, Kochetkov, A I

    Published in Terapevtic̆eskii arhiv (20-09-2018)
    “…The review presents a modern view on stress as a risk factor for the development of arterial hypertension (AH). A variety pathogenic mechanisms responsible for…”
    Get full text
    Journal Article
  3. 3

    Hypertension and insomnia by Ostroumova, T M, Parfenov, V A, Ostroumova, O D, Kochetkov, A I

    Published in Terapevtic̆eskii arhiv (01-01-2020)
    “…Insomnia is frequently detected in patients with arterial hypertension (AH): from 19% to 47.9% of all cases according to epidemiological studies. On the other…”
    Get full text
    Journal Article
  4. 4

    Drug-Induced Atrial Fibrillation / Atrial Flutter by Ostroumova, O. D, Chernyaeva, M. S., Kochetkov, A. I., Vorobieva, A. E., Bakhteeva, D. I., Korchagina, S. P., Bondarets, O. V., Boyko, N. D., Sychev, D. A.

    “…Drug-induced atrial fibrillation / flutter (DIAF) is a serious and potentially life-threatening complication of pharmacotherapy. Purpose of the work:…”
    Get full text
    Journal Article
  5. 5

    Features of the clinical picture in patients of middle age with essential hypertension by Parfenov, V A, Ostroumova, Т М, Ostroumova, O D, Pavleyva, E E

    Published in Terapevtic̆eskii arhiv (20-09-2018)
    “…To evaluate the presence and the severity of the complaints (headache, dizziness, memory loss, concentration of attention, sleep disturbances, decreased mood,…”
    Get full text
    Journal Article
  6. 6

    The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications by Ostroumova, O D, Kochetkov, A I, Pereverzev, A P, Kravchenko, E V, Kazjulin, A N, Andreev, D N, Pavleeva, E E

    Published in Terapevtic̆eskii arhiv (01-01-2019)
    “…In the article the problem of the combined use of clopidogrel and various proton pump inhibitors (PPIs) in terms of cardiovascular complications risk and stent…”
    Get full text
    Journal Article
  7. 7

    Blood pressure variability and risk for complications in arterial hypertension by Ostroumova, O D

    Published in Terapevtic̆eskii arhiv (01-01-2012)
    “…The lecture gives the definition and lists the types of blood pressure variability. It considers the importance of different types of blood pressure…”
    Get full text
    Journal Article
  8. 8

    Drug-Induced Cognitive Impairment and Dementia by Ostroumova, O. D., Ostroumova, T. M., Kochetkov, A. I., Vorobyova, A. E., Gadzhibekov, A. A., Sychev, D. A.

    Published in Neuroscience and behavioral physiology (01-07-2024)
    “…Causes of the development or aggravation of cognitive impairment (CI) may include the use of a number of drugs, including non-steroidal anti-inflammatory…”
    Get full text
    Journal Article
  9. 9

    Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation by Ostroumova, O. D., Ostroumova, T. M.

    “…Atrial fibrillation (AF) is the main cause of cardioembolic ischemic stroke (IS), it occurs in 25–35% of patients with IS, and its presence increases the risk…”
    Get full text
    Journal Article
  10. 10

    The problem of choice: original drug or generic? Emphasis on rosuvastatin by Polyakova, O. A., Ostroumova, O. D.

    “…An increase in the life expectancy of the population and the number of polymorbid patients with a combination of two or more diseases in different age…”
    Get full text
    Journal Article
  11. 11

    Heart failure as a risk factor of adverse drug reactions. Part 2: potential changes in pharmacokinetics of some drugs by Pereverzev, A. P., Ostroumova, O. D.

    “…Drug administration, can be potentially associated with adverse drug reactions (ARDs), including serious ones, contributing to an increase in the risk of death…”
    Get full text
    Journal Article
  12. 12

    Heart failure as a risk factor of adverse drug reactions. Part 1: potential changes in pharmacokinetics by Pereverzev, A. P., Ostroumova, O. D.

    “…The use of many drugs is associated with the risk of adverse drug reactions (ADRs), including those that increase mortality and / or morbidity and / or seek…”
    Get full text
    Journal Article
  13. 13

    Food-drug interaction as a risk factor of drug-induced diseases: epidemiology, risk factors, potential mechanisms of interaction by Pereverzev, A. P., Ostroumova, O. D.

    “…Any drug is potentially associated with the risk of adverse drug reactions (ADRs), the incidence of which in developed and developing countries is estimated at…”
    Get full text
    Journal Article
  14. 14

    Prospects for using a perindopril/amlodipine combination in patients with hypertension and/or coronary artery disease and COVID-19: focus on the endothelium by Polyakova, O. A., Kochetkov, A. I., Ostroumova, O. D.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (01-04-2022)
    “…The outbreak of the coronavirus disease 2019 (COVID-19) pandemic is an ongoing public health emergency that has caused unprecedented morbidity and mortality…”
    Get full text
    Journal Article
  15. 15

    Drug-induced tremor by Ostroumova, T. M., Tolmacheva, V. A., Ostroumova, O. D.

    “…Drug-induced tremor (DIT) is a term used to describe tremors that develop or increase in severity due to various medications administration. As multiple drugs…”
    Get full text
    Journal Article
  16. 16

    Genetic Risk Factors for Adverse Drug Reactions by Sychev, D. A., Chernyaeva, M. S., Ostroumova, O. D.

    “…The use of medicines may in some cases be associated with the development of drug-induced diseases (DIDs) аnd other adverse drug reactions (ADRs), which leads…”
    Get full text
    Journal Article
  17. 17

    Trimethylamine oxide and its possible role in the development and progression of cardiovascular disease by Kochetkov, A. I., Klepikova, M. V., Ostroumova, O. D.

    “…Cardiovascular diseases continue to be the leading cause of death throughout the world and in Russia. Therefore, new possible risk factors for their…”
    Get full text
    Journal Article
  18. 18

    Drugs associated with DIP by Ostroumova, T. M., Ostroumova, O. D., Soloveva, A. S.

    Published in Medicinskij sovet (01-12-2021)
    “…Drug-induced parkinsonism (DIP) is one of the most frequent extrapyramidal disorders that develops against the background of prescribing a large number of…”
    Get full text
    Journal Article
  19. 19

    Drug-Induced Acute Kidney Injury by Zakharova, E. V., Ostroumova, O. D., Klepikova, M. V.

    “…Drug-induced nephrotoxicity is the third most common cause of acute kidney injury (AKI). The aim of the study was to analyse and summarise data on the factors…”
    Get full text
    Journal Article
  20. 20

    Drug-induced ischemic stroke by Ostroumova, T. M., Ostroumova, O. D., Filippova, Yu. A.

    Published in Medicinskij sovet (19-09-2021)
    “…Stroke is an acute disturbance of the blood supply to the brain, characterized by the sudden onset of focal neurological symptoms, which persists for more than…”
    Get full text
    Journal Article